SILOTON LIMITED

12542558
Active Nottingham

Manufacture of medical and dental instruments and supplies

5 employees website.com
Life sciences and medical technology Manufacture of medical and dental instruments and suppliesOther engineering activities +1
S

SILOTON LIMITED

12542558

Manufacture of medical and dental instruments and supplies

Founded 1 Apr 2020 Active Nottingham, England 5 employees website.com
Life sciences and medical technology Manufacture of medical and dental instruments and suppliesOther engineering activitiesOther research and experimental development on natural sciences and engineering
Accounts Submitted 21 Nov 2025 Next due 31 Jan 2027 7 months remaining
Confirmation Submitted 7 Apr 2026 Next due 14 Apr 2027 10 months remaining
Net assets £262K £21K 2025 year on year
Total assets £273K £21K 2025 year on year
Total Liabilities £12K £548 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

69 Loughborough Road West Bridgford Nottingham NG2 7LA England

Website

www.example.com

Full company profile for SILOTON LIMITED (12542558), an active life sciences and medical technology company based in Nottingham, England. Incorporated 1 Apr 2020. Manufacture of medical and dental instruments and supplies. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 May → 30 Apr 2025
Type micro-entity
Next accounts 30 Apr 2026
Due by 31 Jan 2027 7 months remaining

Net Assets, Total Assets & Total Liabilities (2021–2025)

Cash in Bank

N/A

Net Assets

£261.50k

Decreased by £20.81k (-7%)

Total Liabilities

£11.76k

Decreased by £548.00 (-4%)

Turnover

N/A

Employees

5

Debt Ratio

4%

Financial History

Revenue, profit, EBITDA and key financial figures

2025
30 Apr Year End
2024
30 Apr Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 2Mar 2022Seed
Investor 5Dec 2023Seed
Investor 1Jul 2024Seed

Share Capital

Share Capital

Share allotments and capital structure

10 Allotments 10,852 Shares £1.31m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
27 Feb 2026899£313k£348.25
24 Jul 202480£19k£239.83
24 May 2024584£140k£239.83
8 May 2024250£60k£239.83
14 Dec 2023251£60k£239.83

Officers

Officers

3 active
Status
Allen, Euan John, Dr.DirectorBritishUnited Kingdom351 Apr 2020Active
Price, Alasdair Benjamin, Dr.DirectorBritishEngland341 Apr 2020Active
Reid, Ian PaulDirectorBritishEngland6618 Dec 2020Active

Shareholders

Shareholders (27)

Euan John Allen
24.0%
5,000
Alasdair Benjamin Price
24.0%
5,000

Persons with Significant Control

Persons with Significant Control (2)

2 Active 2 Ceased

Euan John Allen

British

Active
Notified 1 Apr 2020
Residence United Kingdom
DOB February 1991
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Alasdair Benjamin Price

British

Active
Notified 1 Apr 2020
Residence England
DOB May 1992
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Dr. Euan John Allen

Ceased 27 Feb 2026

Ceased

Dr. Alasdair Benjamin Price

Ceased 27 Feb 2026

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
7 Apr 2026Persons With Significant ControlNotification of a person with significant control statement
7 Apr 2026Persons With Significant ControlCessation of Euan John Allen as a person with significant control on 27 Feb 2026
7 Apr 2026Confirmation StatementConfirmation statement made on 31 Mar 2026 with updates
7 Apr 2026Persons With Significant ControlCessation of Alasdair Benjamin Price as a person with significant control on 27 Feb 2026
11 Mar 2026CapitalAllotment of shares (GBP 208.52) on 27 Feb 2026
7 Apr 2026 Persons With Significant Control

Notification of a person with significant control statement

7 Apr 2026 Persons With Significant Control

Cessation of Euan John Allen as a person with significant control on 27 Feb 2026

7 Apr 2026 Confirmation Statement

Confirmation statement made on 31 Mar 2026 with updates

7 Apr 2026 Persons With Significant Control

Cessation of Alasdair Benjamin Price as a person with significant control on 27 Feb 2026

11 Mar 2026 Capital

Allotment of shares (GBP 208.52) on 27 Feb 2026

Recent Activity

Latest Activity

Notification of a person with significant control statement

2 months ago on 7 Apr 2026

Cessation of Euan John Allen as a person with significant control on 27 Feb 2026

2 months ago on 7 Apr 2026

Confirmation statement made on 31 Mar 2026 with updates

2 months ago on 7 Apr 2026

Cessation of Alasdair Benjamin Price as a person with significant control on 27 Feb 2026

2 months ago on 7 Apr 2026

Allotment of shares (GBP 208.52) on 27 Feb 2026

3 months ago on 11 Mar 2026